Alibaba Health Information Technology (241)
5.27 HKD -0.15 (-2.77%) Volume: 148.64M
Alibaba Health Information Technology’s stock price stands at 5.27 HKD, experiencing a slight dip of -2.77% this trading session with a trading volume of 148.64M, yet boasting a robust year-to-date percentage change of +58.73%, reflecting its resilient market performance.
Latest developments on Alibaba Health Information Technology
Today, Alibaba Health Information Tec stock price experienced significant movements as a result of key events in the market. The company’s shares were influenced by the latest inflation outlook and shifting values that roiled Asian stock markets. Investors closely monitored these developments, leading to fluctuations in the stock price of Alibaba Health Information Tec. As market conditions continue to evolve, the company remains at the forefront of these changes, navigating through the impact on its stock performance.
A look at Alibaba Health Information Technology Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 1 | |
| Growth | 5 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Alibaba Health Information Technology Limited, an integrated healthcare information and content service provider, has received a mixed outlook based on the Smartkarma Smart Scores. While the company scored high in Growth, Resilience, and Momentum, its Value and Dividend scores were lower. This suggests that Alibaba Health Information Tec may have strong potential for growth and resilience in the long term, but investors looking for value or dividend income may need to consider other options.
With a strong emphasis on growth, resilience, and momentum, Alibaba Health Information Technology Limited seems poised for success in the healthcare information sector. The company’s focus on product identification, authentication, and tracking system data sets it apart as a key player in the industry. While there may be room for improvement in terms of value and dividend offerings, Alibaba Health Information Tec‘s overall outlook appears positive for those seeking long-term growth potential.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
